NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50881-007-04 | 50881-007 | HUMAN PRESCRIPTION DRUG | OPZELURA | ruxolitinib | CREAM | TOPICAL | 20210921 | N/A | NDA | NDA215309 | Incyte Corporation | RUXOLITINIB PHOSPHATE | 15 mg/g | 1 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE |
50881-007-05 | 50881-007 | HUMAN PRESCRIPTION DRUG | OPZELURA | ruxolitinib | CREAM | TOPICAL | 20210921 | N/A | NDA | NDA215309 | Incyte Corporation | RUXOLITINIB PHOSPHATE | 15 mg/g | 1 TUBE in 1 CARTON (50881-007-05) / 60 g in 1 TUBE |
50881-007-07 | 50881-007 | HUMAN PRESCRIPTION DRUG | OPZELURA | ruxolitinib | CREAM | TOPICAL | 20220415 | N/A | NDA | NDA215309 | Incyte Corporation | RUXOLITINIB PHOSPHATE | 15 mg/g | 1 TUBE in 1 CARTON (50881-007-07) / 100 g in 1 TUBE |